Deemagarn Taweewat, Carpena Xavier, Singh Rahul, Wiseman Ben, Fita Ignacio, Loewen Peter C
Department of Microbiology, University of Manitoba, Winnipeg, MB, Canada R3T 2N2.
J Mol Biol. 2005 Jan 7;345(1):21-8. doi: 10.1016/j.jmb.2004.10.020.
The Ser315Thr variant of the catalase-peroxidase KatG from Mycobacterium tuberculosis imparts resistance to the pro-drug isonicotinic acid hydrazide (isoniazid) through a failure to convert it to the active drug, isonicotinoyl-NAD. The equivalent variant in KatG from Burkholderia pseudomallei, Ser324Thr, has been constructed, revealing catalase and peroxidase activities that are similar to those of the native enzyme. The other activities of the variant protein, including the NADH oxidase, the isoniazid hydrazinolysis and isonicotinoyl-NAD synthase activities are reduced by 60-70%. The crystal structure of the variant differs from that of the native enzyme in having the methyl group of Thr324 situated in the entrance channel to the heme cavity, in a modified water matrix in the entrance channel and heme cavity, in lacking the putative perhydroxy modification on the heme, in the multiple locations of a few side-chains, and in the presence of an apparent perhydroxy modification on the indole nitrogen atom of the active-site Trp111. The position of the methyl group of Thr324 creates a constriction or narrowing of the channel leading to the heme cavity, providing an explanation for the lower reactivity towards isoniazid and the slower rate of isonicotinoyl-NAD synthesis.
结核分枝杆菌过氧化氢酶-过氧化物酶KatG的Ser315Thr变体由于无法将前药异烟肼转化为活性药物异烟酰-NAD,从而赋予了对异烟肼的抗性。在假鼻疽伯克霍尔德菌的KatG中构建了等效变体Ser324Thr,其过氧化氢酶和过氧化物酶活性与天然酶相似。变体蛋白的其他活性,包括NADH氧化酶、异烟肼肼解和异烟酰-NAD合酶活性降低了60-70%。该变体的晶体结构与天然酶的晶体结构不同,Thr324的甲基位于血红素腔的入口通道中,入口通道和血红素腔中的水基质发生了改变,血红素上缺乏假定的过羟基修饰,一些侧链处于多个位置,并且活性位点Trp111的吲哚氮原子上存在明显的过羟基修饰。Thr324甲基的位置导致通向血红素腔的通道变窄或收缩,这为对异烟肼的反应性较低以及异烟酰-NAD合成速率较慢提供了解释。